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Abstract We have recently identified a synthetic peptide,
termed C3, capable of binding the first immunoglobulin-like
module of neural cell adhesion molecule (NCAM) by means of
combinatorial chemistry and shown that this NCAM ligand
promotes neurite outgrowth. By means of single cell calcium
imaging using the calcium-sensitive probe fura-2-acetomethyl
ester, we here show that the C3-peptide induced an increase in
intracellular calcium in primary hippocampal neurons and PC12-
E2 cells, presumably requiring mobilization of calcium from both
extracellular and intracellular stores. We further observed that
C3-induced neurite outgrowth was inhibited by antagonists of
voltage-dependent calcium channels as well as by an inhibitor of
intracellular calcium mobilization, TMB-8. These findings
demonstrate at the single cell level that a synthetic NCAM
ligand directly can induce an increase in intracellular calcium and
suggest that NCAM-dependent neurite outgrowth requires
calcium mobilization from both extracellular and intracellular
calcium stores. Thus, the C3-peptide may be regarded as a
useful tool for the study of NCAM-dependent signal transduc-
tion. Furthermore, the peptide may be of considerable therapeu-
tical interest for the treatment of neurodegenerative dis-
orders. ß 2002 Federation of European Biochemical Socie-
ties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The neural cell adhesion molecule (NCAM) plays a key role
in the development of the nervous system by modulating axo-
nal outgrowth and fasciculation. In addition, NCAM has
been shown to be involved in synaptic plasticity associated
with learning and memory [1^3]. Thus, spatial learning is im-
paired in NCAM-de¢cient mice [4] and intracranial injection
of NCAM-antibodies in a time window of 5^7 h after a learn-
ing session inhibits learning in rats or chicks in models of
passive avoidance learning [5,6]. In addition, long-term poten-
tiation is impaired in hippocampal slice cultures from NCAM-
de¢cient mice and in normal tissue slices after injection of
NCAM antibodies [7^10].
NCAM binds homophilically (NCAM binding to NCAM)
as well as heterophilically (NCAM binding to another ligand
or counter-receptor), thereby mediating intercellular adhesion
and adhesion between cells and the extracellular matrix. Ho-
mophilic NCAM binding probably depends on a double re-
ciprocal interaction between the immunoglobulin-I (IgI) and
IgII modules of two opposing NCAM molecules [11^15]
although interactions between two opposing IgIII modules
[16], or an antiparallel interaction between opposing IgI^IgV
modules [17] also have been suggested to contribute to
NCAM binding. Upon homophilic NCAM binding, neurite
outgrowth is induced via activation of a signalling cascade
that presumably includes activation of ¢broblast growth fac-
tor (FGF) receptors, PKC and the Ras-MAPK pathway [18^
20].
It has been shown that neurite outgrowth induced by ho-
mophilic NCAM binding in cocultures of neurons and
NCAM-transfected ¢broblasts is inhibited by antagonists of
voltage-dependent calcium channels (VDCCs), suggesting that
a calcium in£ux through VDCCs may be necessary for
NCAM-induced neurite outgrowth [21]. Likewise, the homo-
philic binding of another cell adhesion molecule, L1, has been
shown to induce neurite outgrowth [18] and it has been re-
ported that soluble Fc-chimeras of L1 induce a calcium in£ux
through VDCCs although without a concomitant rise in bulk
intracellular calcium [22]. Moreover, by spectro£uorimetry
NCAM antibodies have been shown to induce a long-lasting
increase in intracellular calcium in PC12 cells [23] and primary
cerebellar neurons [24].
By means of a combinatorial library of synthetic peptides,
we have recently identi¢ed a ligand of the N-terminal NCAM
Ig module (IgI), termed the C3-peptide, which promotes neu-
rite outgrowth from primary hippocampal neurons and PC12-
E2 cells. This e¡ect can be inhibited by verapamil and
g-conotoxin GVIA, indicating a signalling pathway involving
calcium in£ux through VDCCs [25]. We here studied the
role of calcium channels in neurite outgrowth induced by
the C3-peptide and further used single cell calcium imaging
to investigate whether the C3-peptide a¡ected intracellular
calcium in primary hippocampal neurons and PC12-E2 cells.
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2. Materials and methods
2.1. Cell culture
The PC12-E2 cell line [26], a gift from Dr. Klaus Seedorf, Hagedorn
Research Institute, Gentofte, Denmark, was grown in Dulbecco’s
modi¢ed Eagle’s medium (DMEM; Gibco BRL, Paisley, Scotland,
UK) supplemented with 10% horse serum (HS; Sigma, St. Louis,
MO, USA), 5% fetal bovine serum (FBS; Sigma) penicillin (100 U/
ml, Sigma) and streptomycin (100 Wg/ml, Sigma). Dissociated hippo-
campal cells were obtained from embryonic day 18 Wistar rats as
previously described [27]. Brie£y, hippocampi were dissected in a
cold modi¢ed Krebs^Ringer solution (Gibco BRL). After removal
of meninges, the tissue was roughly homogenized by chopping with
a scalpel blade and thereafter trypsinizing for 5 min at room temper-
ature. Cells were then washed in the presence of DNase I (Sigma) and
soybean trypsin inhibitor (Sigma) and thereafter triturated. All ani-
mals were handled in accordance with the national guidelines for
animal welfare. For analysis of neurite outgrowth, 5000 cells/well
were seeded in 8-well LabTek tissue culture chamber slides with a
growth surface of Permanox plastic coated with ¢bronectin (10 Wg/
ml, Sigma) and grown in Neurobasal medium supplemented with B27
(Gibco, BRL), 20 mM HEPES (Gibco BRL), 0.4% w/v bovine serum
albumin (BSA; Sigma), penicillin (100 U/ml) and streptomycin (100
Wg/ml). After 21 h, cultures were ¢xed using 4% w/v paraformalde-
hyde, washed in phosphate-bu¡ered saline and stained with Coomas-
sie blue (4 g/l Coomassie brilliant blue, 45% v/v ethanol, 10% v/v
acetic acid). Reagents to be tested were added immediately after seed-
ing of cells and included g-conotoxin MVIIA (CgTx MVIIA), nifedi-
pine and g-agatoxin TK (AgaTxTK; Alomone Labs, Jerusalem, Is-
rael), TMB-8 (8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
hydrochloride; Calbiochem, La Jolla, CA, USA) and Igs recognizing
NCAM puri¢ed from a rabbit polyclonal NCAM antiserum using a
protein-A Sepharose column as previously described [7].
2.2. Analysis of neurite outgrowth
After 21 h in culture, images of cultures were grabbed and analyzed
by means of computer-assisted microscopy. The total neurite length
per cell was analyzed by means of a stereological method using the
software Processlength [28]. Brie£y, the total length of neurites per cell
was estimated by counting the number of intersections between neu-
rites and the test lines of an unbiased counting frame. The absolute
neurite length (L) was calculated using the equation L = (ZWd/2)WI in
which I represents the number of neurite intersections per cell and d
represents the vertical distance between the test lines of the counting
frame.
2.3. Calcium imaging
Hippocampal cells were seeded on 4- or 8-well ¢bronectin-coated
LabTek chambered coverglass slides (NUNC, Roskilde, Denmark) at
a density of 10^50 000 cells/well and grown for 1^21 days in Neuro-
basal medium supplemented with B27, 20 mM HEPES, 0,4% w/v
BSA, penicillin (100 U/ml) and streptomycin (100 Wg/ml). Approxi-
mately two thirds of the medium were exchanged every third day.
PC12-E2 cells were dislodged mechanically by tapping and seeded
at a density of 5000-30 000 cells/cm2 in 4- or 8-well LabTek cham-
bered coverglass slides (NUNC) with a growth surface of plastic
coated with ¢bronectin (10 Wg/ml, Sigma) and grown for 1^5 days.
In some cases, neuronal di¡erentiation was induced by changing the
medium to DMEM supplemented with 1% FBS, 1% HS and nerve
growth factor (NGF; 50 ng/ml, Alomone) or FGF-2 (10 ng/ml, Alo-
mone). Cells were washed with Krebs^Ringer solution comprising
KCl (5 mM), NaCl (116 mM), NaHCO3 (20 mM), MgCl2 (1 mM),
Na2HPO4 (3 mM), CaCl2 (1 mM), HEPES (5 mM) and loaded with
Fura-2 acetomethyl ester (Fura-2-AM; 2 WM; Molecular Probes, Eu-
gene, OR, USA) dissolved in dimethyl sulfoxide for 35 min at 20‡C in
the dark. In some cases Hanks’ balanced salt solution (Sigma) com-
prising KCl (5.4 mM), NaCl (137 mM), NaHCO3 (2 mM), MgSO4
(0.8 mM), Na2HPO4 (0.27 mM), glucose (5.6 mM), CaCl2 (1.25 mM),
KH2PO4 (0.44 mM) was used instead of Krebs^Ringer solution. Sub-
sequently, cells were washed four times and placed on the stage of an
inverted Axiovert 135 TV microscope (Zeiss, Go«ttingen, Germany)
equipped with an oil immersion UV objective (Zeiss Fluar 40U, 1.3
numerical aperture). Imaging was performed using a sensicam 12 bit
cooled CCD camera (PCO, Keilheim, Germany) and a JpM mono-
chromator (JpM, Aalen, Germany). In some cases, an Axiovert 135
inverted microscope (Zeiss) equipped with an oil immersion UV ob-
jective (Zeiss Achrostigmat 40U, 1.3 numerical aperture), a ¢lter
wheel, a CCD-72 video camera and a Gen II sys image intensi¢er
(DAGE-MIJ, Michigan City, MI, USA) were used for calcium imag-
ing. As software for data acquisition and analysis either Imaging
Workbench (Axon, Foster City, CA, USA) or Meta£uor (Universal
Imaging, West Chester, PA, USA) were used. Ratio images were
obtained after background subtraction from images collected at wave-
lengths over 510 nm after excitation at 340 and 380 nm respectively at
sampling rates between 0.1 and 1 Hz. Calibration was performed
using CaEGTA/K2EGTA bu¡ers with known concentrations of free
calcium (Molecular Probes) and Fura-2 pentapotassium salt (5 WM,
Molecular Probes). Concentration of free calcium was estimated as,
[Ca2]i = KdU(R3Rmin)/(Rmax3R)U(F380max/F380min), where R is
the ratio of background subtracted £uorescence intensities obtained
at excitation at 340 and 380 nm respectively, Rmax is the ratio at
saturating calcium, Rmin is the ratio at zero free calcium, F380min is
the intensity at saturating free calcium exciting at 380 nm, while
F380max is the intensity at zero free calcium. Rmax was determined
in situ using Fura-2-AM-loaded cells in the presence of 5 WM iono-
mycin (Molecular Probes) and 10 mM extracellular calcium. Values
determined were: Rmax 9.0; Rmin 0.68; F380max/F380min 7.0. The Kd
used was 236 nM [29]. Bu¡er with nominally zero calcium was pre-
pared as described above except that the NaCl molarity was increased
correspondingly to compensate for the decreased ionic strength. For
experiments using zero calcium bu¡er, cells were carefully washed ¢ve
times in the bu¡er before being used for imaging. Peptides and other
compounds to be tested were applied directly to the cell culture cham-
bers in a volume corresponding to half of the volume present in the
chamber prior to application to ensure an even distribution of the
compound.
2.4. Peptide synthesis
Peptide dendrimers consisting of four peptide monomers coupled to
a lysine backbone were synthesized on a TentaGel resin (Rapp Poly-
mere, Tu«bingen, Germany) with the Rink amide linker (Novabio-
chem, La«ufel¢ngen, Switzerland) using 9-£uorenylmethoxycarbonyl-
protected amino acids (Novabiochem) as previously described [25].
The peptides were at least 95% pure as estimated by HPLC. Concen-
trations of peptide dendrimers were calculated according to the
amount of peptide monomers. The sequence of the C3-peptide is
ASKKPKRNIKA. Two peptides comprising the C3-sequence with
two or four alanine substitutions, ASKKPAANIKA (C3 2ala) and
ASAAPAANIKA (C3 4ala), were used as controls for the C3-peptide.
The dendrimer of the C3-peptide is termed C3d.
3. Results
3.1. Neurite outgrowth induced by C3d is inhibited by calcium
channel antagonists
In order to investigate the role of intracellular calcium in
the signalling pathway activated by the C3-peptide ligand of
NCAM, primary hippocampal neurons were grown for 24 h
in the presence of antagonists of VDCCs or in the presence of
TMB-8, which has been reported to be an inhibitor of intra-
cellular calcium mobilization [30]. As previously observed, the
dendrimeric form of C3, C3d, stimulated neurite outgrowth
from primary hippocampal neurons at a concentration of 0.75
WM (Fig. 1). Thus, in the presence of C3d, the neurite length
per cell was approximately twice as large as the length of
neurites from cells grown in the absence of peptide. This in-
crease in neurite length was inhibited partially by the presence
of either CgTx MVIIA (1 WM), nifedipine (10 WM) or
AgaTxTK (0.1 WM), which are antagonists of N-type,
L-type and P/Q-calcium channels, respectively. The possible
involvement of N- and L-type calcium channels in NCAM-
dependent neurite outgrowth induced by either the C3-peptide
[25] or homophilic NCAM binding in neuron^¢broblast co-
cultures [21] has previously been demonstrated using the com-
pounds verapamil, diltiazem and g-conotoxin GVIA. The
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present ¢ndings support the involvement of N- and L-type
calcium channels and furthermore imply that activation of
P/Q-type calcium channels upon NCAM binding also may
be necessary for neurite outgrowth stimulated by C3d.
To investigate the involvement of intracellular calcium
stores in NCAM-dependent neurite outgrowth, we tested the
e¡ect of TMB-8, an inhibitor of intracellular calcium mobili-
zation [30], on neurite outgrowth induced by the C3-peptide.
TMB-8 blocked the neurite outgrowth response to the C3-
peptide completely in a concentration of 10 WM, and it was
partially inhibiting at a concentration of 1 WM. This indicates
that mobilization of calcium from intracellular stores may be
required for neurite outgrowth induced by NCAM binding,
and this mobilization probably acts in concert with a calcium
in£ux through VDCCs in the plasma membrane.
3.2. The C3-peptide induces an increase in intracellular calcium
in PC12-E2 cells
By means of spectro£uorometry, it has previously been
shown that polyclonal antibodies against NCAM induce an
increase in the average intracellular concentration of calcium
in quin-2-loaded PC12 cells when applied in relatively high
concentrations (0.4^1 mg/ml) [23]. Using a similar method,
recombinant NCAM fragments or puri¢ed NCAM from
mouse brain were shown to increase intracellular calcium in
cerebellar neurons [24,31].
Here, we have used imaging of single Fura-2-loaded PC12-
E2 cells to investigate whether the C3-peptide was capable of
modulating intracellular calcium. When applied at a concen-
tration of 50 WM, C3 induced a sustained increase in intra-
cellular calcium in undi¡erentiated PC12-E2 cells as shown in
Figs. 2 and 3A. The cells responded heterogenously, with
some cells displaying slow oscillations in intracellular calcium.
A similar response was observed after a neuronal phenotype
had been induced in the PC12-E2 cells by pre-treatment with
NGF or FGF-2 (not shown). When C3d was applied in nom-
inally Ca2-free conditions, a signi¢cant reduction in the re-
sponse was observed (Fig. 3B), indicating that the C3-induced
increase in the intracellular calcium concentration is depen-
dent on in£ux of calcium from extracellular sources. However,
the ¢nding that in the absence of extracellular calcium C3d
still induced a small, transient increase in intracellular calcium
suggests that mobilization of calcium from internal stores also
contributes to the response. As the increase in the intracellular
calcium concentration under these conditions was only tran-
sient, this indicates that VDCCs in the plasma membrane are
necessary for the sustained increase in intracellular calcium
observed after C3 application. However, the diminished
Ca2 signalling from internal stores in Ca2-free medium
could also be due to a partial depletion of intracellular
Ca2 stores under these conditions. In the presence of
TMB-8 the response to C3d was smaller and the onset was
slower than in the absence of TMB-8, supporting the notion
that mobilization of calcium from intracellular stores is in-
duced by C3d (Fig. 3C). A C3-control peptide with no neu-
6
Fig. 1. E¡ect of calcium channel antagonists on neurite outgrowth
induced by C3d. A: Micrograph of primary hippocampal neurons,
bar = 20 Wm. B: Primary hippocampal neurons grown in the pres-
ence of C3d (0.75 WM). C: Primary hippocampal neurons grown in
the presence of C3d (0.75 WM) and TMB-8 (10 WM). D: Total
length of neurites in primary hippocampal cell cultures grown in the
absence or presence of C3d and the calcium channel antagonists
TMB-8, CgTx MVIIA (cMVIIA), AgaTxTK (aTK) and nifedipine
(Nif) (concentrations in WM are indicated). The results are shown as
means þ S.E.M. from six to nine independent experiments,
*P6 0.05, **P6 0.01, ***P6 0.001 (paired t-test).
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ritogenic activity [25], C3d 2ala, had no measurable e¡ect on
intracellular calcium (Fig. 3D).
3.3. The e¡ect of the C3-peptide on intracellular calcium in
primary hippocampal neurons
We subsequently studied the e¡ect of the C3-peptide on
Fura-2-loaded primary hippocampal neurons in order to re-
late the apparent dependence of C3-induced neurite out-
growth to the observed changes in intracellular calcium
(Fig. 4). As in PC12-E2 cells, a sustained increase in intra-
cellular calcium was observed in primary hippocampal neu-
rons upon application of 54 WM C3d (Fig. 4A). In contrast, a
C3-control peptide with no neuritogenic activity, C3d 4ala
[25], had no measurable e¡ect on intracellular calcium. In
addition, polyclonal antibodies against NCAM elicited an in-
crease in intracellular calcium, while Igs from non-immune
serum had no e¡ect (Fig. 4B). When lower concentrations
of C3d were applied, the responses were heterogeneous. Gen-
Fig. 2. C3d induces an increase in intracellular calcium in PC12-E2 cells. A: Micrograph of a Fura-2-AM-loaded PC12-E2 cell before C3d ap-
plication, bar: 20 Wm. B^D: Micrographs of PC12-E2 cells 70 s, 215 s and 420 s after application of C3d (50 WM). E: Time course of the
change in intracellular calcium concentration ([Ca2]i) calculated from the Fura-2 £uorescence ratio following application of C3d (50 WM).
Each trace represents an individual cell.
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erally, only few cells responded measurably to 0.54 WM, while
a higher fraction of cells responded with an increase in intra-
cellular calcium, when C3d was applied in a concentration of
5.4 WM (Fig. 4C). The C3-induced change in intracellular
calcium also appeared to depend on the in vitro di¡erentiation
state of the hippocampal cells. When C3d was applied in
concentrations of 0.54 or 5.4 WM to cells after 24 h in culture
only very few cells (6 5%) responded measurably. After 72 h
in culture a higher but variable fraction of the cells showed a
change in intracellular calcium after application of C3d while
most cells grown for a period of 10^21 days responded to the
C3-peptide. Furthermore, the increase in intracellular calcium
in the responding cells was variable, some cells exhibiting
oscillations in intracellular calcium (Fig. 4D) while others
did not.
4. Discussion
We here show that C3, a synthetic peptide ligand of the
NCAM IgI domain induces an increase in intracellular calci-
um in primary hippocampal neurons and PC12-E2 cells. The
¢ndings demonstrate at the level of individual cells that
NCAM ligands directly can induce an increase in the average
intracellular concentration of calcium in accordance with pre-
Fig. 3. C3d induces mobilization from intracellular calcium stores in PC12-E2 cells. A: E¡ect of C3d application (50 WM) on the intracellular
calcium concentration in Fura-2-AM-loaded PC12-E2 cells. B: E¡ect of C3d on intracellular calcium under nominally calcium-free conditions.
C: E¡ect of C3d on intracellular calcium of PC12-E2 cells pre-treated with TMB-8 (10 WM). D: E¡ect of C3-control peptide, C3d 2ala, on in-
tracellular calcium in PC12-E2 cells. Data in (A^D) are representative of 4^12 independent experiments, each trace representing an individual
cell. E: E¡ect of C3d or C3-control peptide (C3d 2ala) on intracellular calcium in PC12-E2 cells in the presence or absence of TMB-8 (10 WM)
or in nominally calcium-free conditions (3calcium). Data points are means þ S.E.M. of 4^12 independent experiments.
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vious reports of increases in the average intracellular calcium
concentration in populations of neuronal cells measured by
spectro£uorimetry [23,24,31]. In addition, our data suggest
that mobilization of calcium from intracellular stores also
contributes to the increase in intracellular calcium induced
by NCAM binding, although extracellular calcium is neces-
sary for a pronounced and sustained increase to occur (Fig.
4).
Both in PC12-E2 cells and primary hippocampal neurons
the calcium response to C3d appears to be heterogeneous.
Interestingly, in some cells the application of C3d induced
oscillations in intracellular calcium, but it remains to be de-
termined whether calcium oscillations induced by NCAM-ac-
tivation are of functional signi¢cance. In the hippocampal cell
cultures the heterogeneous calcium response may be explained
by the heterogeneity in di¡erentiation of the cells. Alterna-
tively, di¡erences in the ‘binding status’ of the cells, in partic-
ular with respect to NCAM may be speculated to be of im-
portance to the C3-induced increase in intracellular calcium.
In this respect it is of interest that intracellular calcium has
been shown to increase in PC12 cells adhering to other PC12
cells when compared to non-adherent cells [23].
The ¢nding that neurite outgrowth induced by C3d is in-
hibited by VDCC antagonists and by a presumed inhibitor of
mobilization of intracellular calcium, TMB-8, indicates that
C3d upon NCAM-binding activates a signalling pathway
that leads to an increase in intracellular calcium dependent
on both intracellular and extracellular sources. The stimula-
tory e¡ect of C3d on neurite outgrowth was readily detected
when primary hippocampal cells were grown for 24 h. How-
ever, when C3d was applied to Fura-2-loaded hippocampal
cells grown for 24 h only, few cells responded to low concen-
trations of C3d with a detectable increase in intracellular cal-
cium. Therefore, it cannot be ruled out that although C3d and
other NCAM ligands can induce an increase in intracellular
calcium, other mechanisms may be responsible for neurite
outgrowth induced by NCAM stimulation. An alternative ex-
planation may be that only small localized calcium £uxes are
necessary to promote neurite outgrowth, and that such calci-
um £uxes are not readily detected by means of the here-em-
ployed calcium imaging method. This is in accordance with
the hypothesis that relatively low changes in intracellular cal-
cium induce neurite outgrowth whereas more pronounced in-
creases in intracellular calcium do not.
In summary, the present study shows that the synthetic
peptide ligand C3 induces an increase in intracellular calcium,
which appears to be necessary for NCAM-dependent neurite
outgrowth, presumably requiring mobilization of calcium
from both intracellular and extracellular calcium stores. Fur-
thermore, the study demonstrates the feasibility of studying
Fig. 4. E¡ect of C3d on intracellular calcium in primary hippocampal neurons. A: E¡ect of C3d (54 WM) and a C3-control peptide, C3d 4ala,
on intracellular calcium in Fura-2-loaded hippocampal cells after 11 days in culture. B: E¡ect of Igs directed against NCAM (aNCAM Ig,
1 mg/ml) and Igs from non-immune serum (ctl Ig) on intracellular calcium in hippocampal cells after 15 days in culture. Datapoints represent
means þ S.E.M. of 40 (A) or 24 (B) cells. C: E¡ect of C3d (0.54 or 5.4 WM) on intracellular calcium in hippocampal cells after 3 days in cul-
ture. Each trace represents one individual cell. D: Oscillations in intracellular calcium induced by C3d (5.4 WM) in hippocampal cell after
3 days in culture.
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signal transduction induced by NCAM in real time at the
single cell level by means of imaging techniques.
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